Literature DB >> 2878092

Antisera to scrapie-associated fibril protein and prion protein decorate scrapie-associated fibrils.

P A Merz, R J Kascsak, R Rubenstein, R I Carp, H M Wisniewski.   

Abstract

Scrapie-associated fibrils (SAF) are an infection-specific structure observed in the unconventional-agent diseases. Polyclonal antisera raised to scrapie proteins were used to test the antigenic relationship between purified fibrils and SAF isolated from non-protease-treated synaptosomal-mitochondrial preparations. The experimental design utilized fibrils from scrapie strain 263K-infected hamsters, scrapie strain 139A-infected mice, and scrapie strain ME7-infected mice. Preparations were examined by negative-stain immune electron microscopy and Western blot analysis of the polypeptides. Fibrils and polypeptides from each preparation reacted with a rabbit antiserum raised to each of the following: hamster 263K prion protein (PrP 27-30), hamster 263K SAF protein, and mouse ME7 SAF protein. Immune electron microscopy and Western blot analysis revealed similar antigenic relationships among the three scrapie antisera. Thus, fibrils and polypeptides can be considered to be the same in each preparation. No reactivity of the fibrils was observed with antisera raised to Alzheimer neurofibrillary tangles or a synthetic peptide of cerebrovascular amyloid. Thus, the fibrils observed in purified preparations share structural and antigenic similarities plus biochemically related peptides with SAF present in non-protease-treated preparations.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2878092      PMCID: PMC255197     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Partial copurification of scrapie-associated fibrils and scrapie infectivity.

Authors:  R A Somerville; P A Merz; R I Carp
Journal:  Intervirology       Date:  1986       Impact factor: 1.763

2.  Detection of scrapie-associated fibril (SAF) proteins using anti-SAF antibody in non-purified tissue preparations.

Authors:  R Rubenstein; R J Kascsak; P A Merz; M C Papini; R I Carp; N K Robakis; H M Wisniewski
Journal:  J Gen Virol       Date:  1986-04       Impact factor: 3.891

3.  Scrapie and Creutzfeldt-Jakob disease prion proteins share physical properties and antigenic determinants.

Authors:  P E Bendheim; J M Bockman; M P McKinley; D T Kingsbury; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

4.  Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone.

Authors:  C J Gibbs; A Joy; R Heffner; M Franko; M Miyazaki; D M Asher; J E Parisi; P W Brown; D C Gajdusek
Journal:  N Engl J Med       Date:  1985-09-19       Impact factor: 91.245

5.  Specific proteins associated with Creutzfeldt-Jakob disease and scrapie share antigenic and carbohydrate determinants.

Authors:  L Manuelidis; S Valley; E E Manuelidis
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

6.  Characterization of antisera against scrapie-associated fibrils (SAF) from affected hamster and cross-reactivity with SAF from scrapie-affected mice and from patients with Creutzfeldt-Jakob disease.

Authors:  L Bode; M Pocchiari; H Gelderblom; H Diringer
Journal:  J Gen Virol       Date:  1985-11       Impact factor: 3.891

7.  Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Authors:  C L Masters; G Simms; N A Weinman; G Multhaup; B L McDonald; K Beyreuther
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

8.  Antibodies to the scrapie protein decorate prion rods.

Authors:  R A Barry; M P McKinley; P E Bendheim; G K Lewis; S J DeArmond; S B Prusiner
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

9.  Biochemical differences among scrapie-associated fibrils support the biological diversity of scrapie agents.

Authors:  R J Kascsak; R Rubenstein; P A Merz; R I Carp; H M Wisniewski; H Diringer
Journal:  J Gen Virol       Date:  1985-08       Impact factor: 3.891

10.  Scrapie PrP 27-30 is a sialoglycoprotein.

Authors:  D C Bolton; R K Meyer; S B Prusiner
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

View more
  16 in total

1.  Immune electron microscopic characterization of monoclonal antibodies to Alzheimer neurofibrillary tangles.

Authors:  M A Wrzolek; P A Merz; R Kascsak; I Grundke-Iqbal; K Iqbal; R Rubenstein; M Tonna-DeMasi; N L Goller; P Mehta; H M Wisniewski
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

2.  N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state.

Authors:  B Caughey; G J Raymond; D Ernst; R E Race
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

3.  Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis.

Authors:  M P McKinley; R K Meyer; L Kenaga; F Rahbar; R Cotter; A Serban; S B Prusiner
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

4.  Scrapie: Report of an outbreak and brief review.

Authors:  L Petrie; B Heath; D Harold
Journal:  Can Vet J       Date:  1989-04       Impact factor: 1.008

5.  Protease sensitivity and nuclease resistance of the scrapie agent propagated in vitro in neuroblastoma cells.

Authors:  K Neary; B Caughey; D Ernst; R E Race; B Chesebro
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

6.  Synthetic scrapie infectivity: interaction between recombinant PrP and scrapie brain-derived RNA.

Authors:  Steve Simoneau; Achim Thomzig; Marie-Madeleine Ruchoux; Nicolas Vignier; Martin L Daus; Anna Poleggi; Pierre Lebon; Sophie Freire; Valerie Durand; Silvia Graziano; Roberta Galeno; Franco Cardone; Emmanuel Comoy; Maurizio Pocchiari; Michael Beekes; Jean-Philippe Deslys; Jean-Guy Fournier
Journal:  Virulence       Date:  2015-01-13       Impact factor: 5.882

7.  Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins.

Authors:  R J Kascsak; R Rubenstein; P A Merz; M Tonna-DeMasi; R Fersko; R I Carp; H M Wisniewski; H Diringer
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

8.  The comparative immunoreactivities of brain amyloids in Alzheimer's disease and scrapie.

Authors:  S A Bobin; J R Currie; P A Merz; D L Miller; J Styles; W A Walker; G Y Wen; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

9.  Congo red inhibition of scrapie agent replication.

Authors:  B Caughey; D Ernst; R E Race
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

10.  Microglia is a component of the prion protein amyloid plaque in the Gerstmann-Sträussler-Scheinker syndrome.

Authors:  M Barcikowska; P P Liberski; J W Boellaard; P Brown; D C Gajdusek; H Budka
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.